Although some countries are beginning to reopen, the long-term impact of COVID-19 on cancer care continues to manifest. According to the IQVIA Institute Global Oncology Trends report, screenings remain at 11% to 23% below baseline levels. Diagnostics for screening and monitoring reached a deficit of 11 million in 2020. It is estimated that nearly 22 […]

Aptitude Health’s CORE events are designed to provide in-depth understanding of practice-specific patterns of care, disease-state treatment choices, and practice challenges and resource needs in different oncology and hematology indications. During the first 4 months of 2021, we conducted 8 different meetings among community oncologists and hematologists to gain insights into current practices in the […]

In May 2021, Aptitude Health held the first virtual CASES meeting in Europe, focusing on the treatment of adult patients with acute myeloid leukemia (AML). Leading European experts from Spain, Italy, and Germany, and a group of practicing hematologists from these countries discussed patient cases and exchanged reflections on experiences and regional variations regarding treatment […]

Clinical research has been greatly challenged in the wake of COVID-19, with 1773 US clinical trials reportedly suspended as of April 21, 2021. Pandemic-related restrictions on in-person visits created obstacles to trial enrollment, data collection, and intervention delivery. As reported in a recent opinion article by Dr Mary McDermott and Dr Anne Newman, even ongoing […]